CFMVX | VMVAX | CFMVX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 1 year | 13 years | - |
Gain YTD | 16.377 | 17.355 | 94% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 39.9M | 30.9B | 0% |
Annual Yield % from dividends | N/A | 2.14 | - |
Returns for 1 year | 28.02 | 27.09 | 103% |
Returns for 3 years | N/A | 13.54 | - |
Returns for 5 years | N/A | 47.45 | - |
Returns for 10 years | N/A | 96.84 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RECIX | 12.48 | -0.01 | -0.08% |
RBC Emerging Markets Ex-China Equity I | |||
MDDVX | 20.62 | -0.04 | -0.19% |
BlackRock Equity Dividend Inv A | |||
BRUMX | 17.61 | -0.11 | -0.62% |
MFS Blended Research Value Equity R4 | |||
PSIFX | 45.74 | -0.61 | -1.32% |
PGIM Quant Solutions Large-Cap Index Z | |||
NGDAX | 29.66 | -0.67 | -2.21% |
Neuberger Berman Large Cap Growth A |